• Clinical experience with integrase inhibitors in HIV-2-infected individuals in Spain 

      Requena, S.; Lozano, A. B.; Caballero, Estrella; García, F.; Nieto, M. C.; Tellez, R.; ...et al.; Soriano, Vicente (1) (Journal of Antimicrobial Chemotherapy, 05/2019)
      Background: HIV-2 is a neglected virus despite estimates of 1-2 million people being infected worldwide. The virus is naturally resistant to some antiretrovirals used to treat HIV-1 and therapeutic options are limited for ...